Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul 29:12:962139.
doi: 10.3389/fcimb.2022.962139. eCollection 2022.

Molecular mechanisms and functions of pyroptosis in sepsis and sepsis-associated organ dysfunction

Affiliations
Review

Molecular mechanisms and functions of pyroptosis in sepsis and sepsis-associated organ dysfunction

Ri Wen et al. Front Cell Infect Microbiol. .

Abstract

Sepsis, a life-threatening organ dysfunction caused by a dysregulated host response to infection, is a leading cause of death in intensive care units. The development of sepsis-associated organ dysfunction (SAOD) poses a threat to the survival of patients with sepsis. Unfortunately, the pathogenesis of sepsis and SAOD is complicated, multifactorial, and has not been completely clarified. Recently, numerous studies have demonstrated that pyroptosis, which is characterized by inflammasome and caspase activation and cell membrane pore formation, is involved in sepsis. Unlike apoptosis, pyroptosis is a pro-inflammatory form of programmed cell death that participates in the regulation of immunity and inflammation. Related studies have shown that in sepsis, moderate pyroptosis promotes the clearance of pathogens, whereas the excessive activation of pyroptosis leads to host immune response disorders and SAOD. Additionally, transcription factors, non-coding RNAs, epigenetic modifications and post-translational modifications can directly or indirectly regulate pyroptosis-related molecules. Pyroptosis also interacts with autophagy, apoptosis, NETosis, and necroptosis. This review summarizes the roles and regulatory mechanisms of pyroptosis in sepsis and SAOD. As our understanding of the functions of pyroptosis improves, the development of new diagnostic biomarkers and targeted therapies associated with pyroptosis to improve clinical outcomes appears promising in the future.

Keywords: cell death; inflammation; pyroptosis; sepsis; sepsis-associated organ dysfunction.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The molecular mechanism of canonical pyroptosis pathway mediated by NLRP3 inflammasome.
Figure 2
Figure 2
The molecular mechanism of non-canonical pyroptosis pathway and other pyroptosis pathways.
Figure 3
Figure 3
Regulation of pyroptosis under sepsis by transcription factors (A), non-coding RNAs (B), epigenetic modifications and PTMs (C).
Figure 4
Figure 4
Crosstalk between pyroptosis and other programmed cell deaths under sepsis.

References

    1. Aglietti R. A., Estevez A., Gupta A., Ramirez M. G., Liu P. S., Kayagaki N., et al. (2016). GsdmD p30 elicited by caspase-11 during pyroptosis forms pores in membranes. Proc. Natl. Acad. Sci. U. S. A. 113 (28), 7858–7863. doi: 10.1073/pnas.1607769113 - DOI - PMC - PubMed
    1. An L., Yang T., Zhong Y., Yin Y., Li W., Gao H. (2021). Molecular pathways in sepsis-induced cardiomyocyte pyroptosis: Novel finding on long non-coding RNA ZFAS1/miR-138-5p/SESN2 axis. Immunol. Lett. 238, 47–56. doi: 10.1016/j.imlet.2021.07.003 - DOI - PubMed
    1. Barriere S. L., Lowry S. F. (1995). An overview of mortality risk prediction in sepsis. Crit. Care Med. 23 (2), 376–393. doi: 10.1097/00003246-199502000-00026 - DOI - PubMed
    1. Biasizzo M., Kopitar-Jerala N. (2020). Interplay between NLRP3 inflammasome and autophagy. Front. Immunol. 11. doi: 10.3389/fimmu.2020.591803 - DOI - PMC - PubMed
    1. Boomer J. S., To K., Chang K. C., Takasu O., Osborne D. F., Walton A. H., et al. (2011). Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 306 (23), 2594–2605. doi: 10.1001/jama.2011.1829 - DOI - PMC - PubMed

Publication types